{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:08:00Z","timestamp":1773050880991,"version":"3.50.1"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/dbp.0b013e3181c35f25","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T05:49:56Z","timestamp":1260164996000},"page":"544-551","source":"Crossref","is-referenced-by-count":26,"title":["Broad Clinical Involvement in a Family Affected by the Fragile X Premutation"],"prefix":"10.1097","volume":"30","author":[{"given":"Weerasak","family":"Chonchaiya","sequence":"first","affiliation":[]},{"given":"Agustini","family":"Utari","sequence":"additional","affiliation":[]},{"given":"Gabriela Marques","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Flora","family":"Tassone","sequence":"additional","affiliation":[]},{"given":"David","family":"Hessl","sequence":"additional","affiliation":[]},{"given":"Randi J.","family":"Hagerman","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4","article-title":"FMRP expression as a potential prognostic indicator in fragile X syndrome.","volume":"84","author":"Tassone","year":"1999","journal-title":"Am J Med Genet"},{"key":"R3-10-20210129","first-page":"3","article-title":"Fragile X Syndrome: Diagnosis, Treatment and Research.","author":"Hagerman","year":"2002"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1097\/00004703-200604002-00012","article-title":"Autism spectrum disorders and attention-deficit\/hyperactivity disorder in boys with the fragile X premutation.","volume":"27","author":"Farzin","year":"2006","journal-title":"J Dev Behav Pediatr"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ajmg.b.20030","article-title":"Clinical features of boys with fragile X premutations and intermediate alleles.","volume":"121B","author":"Aziz","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ajmg.a.32060","article-title":"Expanded clinical phenotype of women with the FMR1 premutation.","volume":"146","author":"Coffey","year":"2008","journal-title":"Am J Med Genet A"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ajmg.a.32439","article-title":"Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey.","volume":"146A","author":"Bailey","year":"2008","journal-title":"Am J Med Genet A"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2006.09.004","article-title":"The FMR1 premutation and reproduction.","volume":"87","author":"Wittenberger","year":"2007","journal-title":"Fertil Steril"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4088\/JCP.08r04476","article-title":"A review of fragile X premutation disorders: expanding the psychiatric perspective.","volume":"70","author":"Bourgeois","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.b.30786","article-title":"Mood and anxiety disorders in females with the FMR1 premutation.","volume":"150B","author":"Roberts","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajmg.b.30241","article-title":"Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.","volume":"139B","author":"Hessl","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/mds.21493","article-title":"Fragile X-associated tremor\/ataxia syndrome: clinical features, genetics, and testing guidelines.","volume":"22","author":"Berry-Kravis","year":"2007","journal-title":"Mov Disord"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/CIA.S1794","article-title":"Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.","volume":"3","author":"Hagerman","year":"2008","journal-title":"Clin Interv Aging"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.","volume":"66","author":"Tassone","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/386296","article-title":"The fragile-X premutation: a maturing perspective.","volume":"74","author":"Hagerman","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/jmg.2006.043950","article-title":"Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats.","volume":"44","author":"Loesch","year":"2007","journal-title":"J Med Genet"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00439-005-1326-8","article-title":"FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure.","volume":"117","author":"Bretherick","year":"2005","journal-title":"Hum Genet"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.fertnstert.2008.07.007","article-title":"Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency.","volume":"92","author":"Streuli","year":"2009","journal-title":"Fertil Steril"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ajmg.a.10099","article-title":"Relationship of deficits of FMR1 gene specific protein with physical phenotype of fragile X males and females in pedigrees: a new perspective.","volume":"118A","author":"Loesch","year":"2003","journal-title":"Am J Med Genet"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/hmg\/10.14.1449","article-title":"Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.","volume":"10","author":"Kenneson","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mrdd.20006","article-title":"Phenotypic variation and FMRP levels in fragile X.","volume":"10","author":"Loesch","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00041444-200106000-00001","article-title":"Chromosomal abnormalities in a clinic sample of individuals with autistic disorder.","volume":"11","author":"Wassink","year":"2001","journal-title":"Psychiatr Genet"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-6-3","article-title":"Cytogenetic abnormalities and fragile-X syndrome in autism spectrum disorder.","volume":"6","author":"Reddy","year":"2005","journal-title":"BMC Med Genet"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/157339608783565770","article-title":"The fragile X family of disorders: a model for autism and targeted treatments.","volume":"4","author":"Hagerman","year":"2008","journal-title":"Curr Pediatric Rev"},{"key":"R25-10-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajmg.a.30229","article-title":"Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors.","volume":"129A","author":"Kaufmann","year":"2004","journal-title":"Am J Med Genet"},{"key":"R26-10-20210129","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004703-200112000-00008","article-title":"The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders.","volume":"22","author":"Rogers","year":"2001","journal-title":"J Dev Behav Pediatr"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1352\/2008.113:427-438","article-title":"Autism profiles of males with fragile X syndrome.","volume":"113","author":"Harris","year":"2008","journal-title":"Am J Ment Retard"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s10803-006-0205-z","article-title":"Autism spectrum phenotype in males and females with fragile X full mutation and premutation.","volume":"37","author":"Clifford","year":"2007","journal-title":"J Autism Dev Disord"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neubiorev.2006.09.007","article-title":"Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X.","volume":"31","author":"Loesch","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"issue":"suppl 71","key":"R30-10-20210129","first-page":"287","article-title":"The fragile X premutation and autistic spectrum disorders.","volume":"A679","author":"Hagerman","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1037\/0894-4105.22.1.48","article-title":"Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor\/ataxia syndrome.","volume":"22","author":"Grigsby","year":"2008","journal-title":"Neuropsychology"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1037\/0894-4105.17.4.646","article-title":"Effect of the fragile X status categories and the fragile X mental retardation protein levels on executive functioning in males and females with fragile X.","volume":"17","author":"Loesch","year":"2003","journal-title":"Neuropsychology"},{"key":"R33-10-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bandc.2004.08.020","article-title":"The emerging fragile X premutation phenotype: evidence from the domain of social cognition.","volume":"57","author":"Cornish","year":"2005","journal-title":"Brain Cogn"},{"key":"R34-10-20210129","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.neuropsychologia.2004.05.002","article-title":"A neuropsychological investigation of male premutation carriers of fragile X syndrome.","volume":"42","author":"Moore","year":"2004","journal-title":"Neuropsychologia"},{"key":"R35-10-20210129","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cortex.2006.11.002","article-title":"Age-dependent cognitive changes in carriers of the fragile X syndrome.","volume":"44","author":"Cornish","year":"2008","journal-title":"Cortex"},{"key":"R36-10-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajmg.a.20214","article-title":"Effect of the fragile X status categories and FMRP deficits on cognitive profiles estimated by robust pedigree analysis.","volume":"122A","author":"Loesch","year":"2003","journal-title":"Am J Med Genet A"},{"key":"R37-10-20210129","first-page":"1","article-title":"The primary cognitive deficit among males with fragile X-associated tremor\/ataxia syndrome (FXTAS) is a dysexecutive syndrome.","author":"Brega","year":"2008","journal-title":"J Clin Exp Neuropsychol"},{"key":"R38-10-20210129","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ajhg.2008.10.021","article-title":"No evidence for a difference in neuropsychological profile among carriers and noncarriers of the FMR1 premutation in adults under the age of 50.","volume":"83","author":"Hunter","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R39-10-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jns.2006.05.016","article-title":"Impairment in the cognitive functioning of men with fragile X-associated tremor\/ataxia syndrome (FXTAS).","volume":"248","author":"Grigsby","year":"2006","journal-title":"J Neurol Sci"},{"key":"R40-10-20210129","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/brain\/awl338","article-title":"Amygdala dysfunction in men with the fragile X premutation.","volume":"130","author":"Hessl","year":"2007","journal-title":"Brain"},{"key":"R41-10-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11682-008-9020-9","article-title":"Reduced hippocampal activation during recall is associated with elevated FMR1 mRNA and psychiatric symptoms in men with the fragile X premutation.","volume":"2","author":"Koldewyn","year":"2008","journal-title":"Brain Imaging Behav"},{"key":"R43-10-20210129","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1093\/hmg\/ddi394","article-title":"Induction of inclusion formation and disruption of lamin A\/C structure by premutation CGG-repeat RNA in human cultured neural cells.","volume":"14","author":"Arocena","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R44-10-20210129","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.febslet.2005.04.004","article-title":"Long CGG-repeat tracts are toxic to human cells: implications for carriers of Fragile X premutation alleles.","volume":"579","author":"Handa","year":"2005","journal-title":"FEBS Lett"},{"key":"R45-10-20210129","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00004703-200412000-00002","article-title":"Autistic spectrum disorder and the fragile X premutation.","volume":"25","author":"Goodlin-Jones","year":"2004","journal-title":"J Dev Behav Pediatr"},{"key":"R46-10-20210129","first-page":"225","article-title":"A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.","volume":"55","author":"Rousseau","year":"1994","journal-title":"Am J Hum Genet"},{"key":"R47-10-20210129","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V","article-title":"Clinical involvement and protein expression in individuals with the FMR1 premutation.","volume":"91","author":"Tassone","year":"2000","journal-title":"Am J Med Genet"},{"key":"R48-10-20210129","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1542\/peds.2008-0317","article-title":"Advances in the treatment of fragile X syndrome.","volume":"123","author":"Hagerman","year":"2009","journal-title":"Pediatrics"},{"key":"R49-10-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mrdd.20007","article-title":"Psychopharmacology in fragile X syndrome\u2014present and future.","volume":"10","author":"Berry-Kravis","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R50-10-20210129","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/ajmg.a.32290","article-title":"Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder.","volume":"146A","author":"Garcia-Nonell","year":"2008","journal-title":"Am J Med Genet A"},{"key":"R51-10-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0887-8994(01)00276-4","article-title":"Antiepileptic drugs: affective use in autism spectrum disorders.","volume":"25","author":"Di Martino","year":"2001","journal-title":"Pediatr Neurol"},{"key":"R52-10-20210129","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/374321","article-title":"Fragile X premutation tremor\/ataxia syndrome: molecular, clinical, and neuroimaging correlates.","volume":"72","author":"Jacquemont","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R53-10-20210129","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/01.wnl.0000269781.10417.7b","article-title":"Volumetric brain changes in females with fragile X-associated tremor\/ataxia syndrome (FXTAS).","volume":"69","author":"Adams","year":"2007","journal-title":"Neurology"},{"key":"R54-10-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/brain\/awh683","article-title":"Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS).","volume":"129","author":"Greco","year":"2006","journal-title":"Brain"},{"key":"R55-10-20210129","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/humrep\/deh635","article-title":"Association of FMR1 repeat size with ovarian dysfunction.","volume":"20","author":"Sullivan","year":"2005","journal-title":"Hum Reprod"},{"key":"R57-10-20210129","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajmg.a.10862","article-title":"Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure.","volume":"117A","author":"Hundscheid","year":"2003","journal-title":"Am J Med Genet A"},{"key":"R58-10-20210129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajmg.1320380221","article-title":"Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features.","volume":"38","author":"Cronister","year":"1991","journal-title":"Am J Med Genet"},{"key":"R59-10-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1352\/0895-8017(2004)109<237:PWACIM>2.0.CO;2","article-title":"Psychological well-being and coping in mothers of youths with autism, Down syndrome, or fragile X syndrome.","volume":"109","author":"Abbeduto","year":"2004","journal-title":"Am J Ment Retard"},{"key":"R60-10-20210129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/YPG.0b013e3282f97e0b","article-title":"Evidence of depressive symptoms in fragile-X syndrome premutated females.","volume":"18","author":"Rodriguez-Revenga","year":"2008","journal-title":"Psychiatr Genet"},{"key":"R61-10-20210129","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1440-1789.2008.00948.x","article-title":"Peripheral nervous system pathology in fragile X tremor\/ataxia syndrome (FXTAS).","volume":"29","author":"Gokden","year":"2009","journal-title":"Neuropathology"},{"key":"R62-10-20210129","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.juro.2006.11.097","article-title":"Testicular and pituitary inclusion formation in fragile X associated tremor\/ataxia syndrome.","volume":"177","author":"Greco","year":"2007","journal-title":"J Urol"},{"key":"R63-10-20210129","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1001\/jama.2008.684","article-title":"Testing for fragile X gene mutations throughout the life span.","volume":"300","author":"Hagerman","year":"2008","journal-title":"JAMA"},{"key":"R64-10-20210129","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2353\/jmoldx.2009.080173","article-title":"Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population.","volume":"11","author":"Fernandez-Carvajal","year":"2009","journal-title":"J Mol Diagn"},{"key":"R65-10-20210129","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10897-007-9099-y","article-title":"Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.","volume":"16","author":"McConkie-Rosell","year":"2007","journal-title":"J Genet Couns"}],"container-title":["Journal of Developmental &amp; Behavioral Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DBP.0b013e3181c35f25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:28:24Z","timestamp":1620952104000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004703-200912000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/dbp.0b013e3181c35f25","relation":{},"ISSN":["0196-206X"],"issn-type":[{"value":"0196-206X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}